Using multicenter ELISA validations, we selected three biomarkers (SEMA7A, SERPINA3, and ITIH4) and confirmed their efficacy in distinguishing NS from syphilis and other brain diseases, including infectious diseases. Here, SEMA7A is linked to brain disorder.